CJC-1295 vs Ipamorelin
What are CJC-1295 and Ipamorelin?
CJC-1295 and Ipamorelin are two synthetic peptides studied as growth hormone secretagogues, meaning compounds examined for their influence on the body's own growth hormone signaling pathways. They are frequently studied together because they act on two different receptors that converge on the same downstream system.
CJC-1295 is a growth hormone releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone releasing peptide (GHRP) that acts on the ghrelin receptor. Their different mechanisms are the reason they are so often paired in research protocols.
This article is intended as a scientific overview for laboratory researchers comparing these compounds. All peptides discussed are sold strictly for in-vitro research and are not for human consumption.
Background: Two Pathways to the Same System
Growth hormone release is regulated by more than one signal. Understanding the two pathways explains why these peptides are studied as complements.
The GHRH Pathway
Growth hormone releasing hormone is produced in the hypothalamus and acts on the GHRH receptor in the pituitary. It is the primary stimulatory signal for growth hormone production. Analogs of GHRH are studied for their ability to engage this pathway with greater stability than the native hormone.
The Ghrelin / GHRP Pathway
A separate pathway runs through the growth hormone secretagogue receptor (GHS-R), the receptor for ghrelin. Growth hormone releasing peptides act here. This pathway works alongside the GHRH pathway, which is why engaging both at once is a common research design.
Direct Comparison: CJC-1295 vs Ipamorelin
The table below summarizes the key research distinctions.
Property — CJC-1295 — Ipamorelin
Class — GHRH analog — GHRP (ghrelin receptor agonist)
Receptor target — GHRH receptor — GHS-R (ghrelin receptor)
Selectivity note — GHRH-pathway stimulus — highly selective GHRP
Half-life — long (with DAC) / short (without DAC) — short
Common research role — sustained pathway signal — selective pulse signal
Frequently paired with — Ipamorelin — CJC-1295
Peptide length — 30 amino acids (analog) — 5 amino acids
CJC-1295: A GHRH Analog
Structure and Background
CJC-1295 is a synthetic analog of GHRH. It is studied in two common forms in the literature — one with a technology called DAC (Drug Affinity Complex) that extends its half-life substantially, and one without DAC, sometimes referenced alongside the name Mod GRF 1-29. The presence or absence of DAC is the single most important variable researchers track with this peptide.
Proposed Mechanisms in Research
CJC-1295 is studied for its engagement of the GHRH receptor, producing a sustained signal compared with native GHRH, which degrades within minutes. The DAC version binds albumin to extend its presence further. Research interest centers on its role as a steady GHRH-pathway stimulus in laboratory models.
Ipamorelin: A Selective GHRP
Structure and Background
Ipamorelin is a pentapeptide and one of the more selective growth hormone releasing peptides studied. Its research appeal comes from selectivity — in the literature it is noted for engaging the ghrelin receptor pathway with comparatively little effect on other hormone systems that some older GHRPs influence.
Proposed Mechanisms in Research
Ipamorelin acts on the GHS-R (ghrelin receptor). Because this is a different receptor from the one CJC-1295 targets, the two peptides can engage their respective pathways simultaneously. This complementary action is the basis for the frequently studied CJC-1295 plus Ipamorelin combination.
Current Research Areas
Shared research areas
The two peptides overlap heavily because of their complementary pathways:
- Growth hormone secretagogue signaling studies
- Combination-protocol research examining dual-pathway engagement
- Pituitary signaling and pulse-pattern models
Why they are combined
Because CJC-1295 engages the GHRH receptor and Ipamorelin engages the ghrelin receptor, studying them together lets researchers examine both stimulatory pathways at once. The combination is one of the most referenced peptide pairings in growth hormone secretagogue research for this reason.
Conclusion
CJC-1295 and Ipamorelin are studied together so often that they are sometimes treated as a single unit, but they are distinct peptides working through distinct receptors. CJC-1295 is a GHRH analog providing a sustained pathway signal, while Ipamorelin is a selective ghrelin-receptor peptide. The combination is popular in research precisely because the two pathways are complementary. For laboratories, the critical handling detail remains confirming the DAC status of any CJC-1295 product.
This article is a summary of publicly available scientific literature and does not constitute medical advice. CJC-1295, Ipamorelin, and all peptide compounds sold by Prime Peptide Solutions are intended strictly for laboratory research and are not for human consumption, in-vivo human use, or therapeutic application. Researchers are responsible for compliance with all applicable regulations governing peptide use in their jurisdiction.
Shop these compounds
Frequently Asked Research Questions
Why are CJC-1295 and Ipamorelin studied together?
They act on two different receptors that both influence growth hormone release. Combining them lets researchers engage both pathways simultaneously, which neither peptide does alone.
What is the difference between CJC-1295 with and without DAC?
The DAC (Drug Affinity Complex) version binds albumin to extend its half-life dramatically. The non-DAC version, sometimes called Mod GRF 1-29, has a much shorter duration. Researchers should always confirm which form they are handling.
Is either peptide approved for human use?
No. Both are research compounds sold strictly for in-vitro laboratory study and are not for human consumption or in-vivo human use.
What makes Ipamorelin described as selective?
In the literature it is noted for engaging the ghrelin receptor pathway with comparatively little effect on other hormone systems that some earlier growth hormone releasing peptides also influenced.
What purity should research-grade material have?
High purity verified by HPLC and confirmed by mass spectrometry, with the exact figure stated on a batch-specific Certificate of Analysis.